logo
Algebrik AI and Open Lending Partner to Expand Intelligent Auto Loan Decisioning for Credit Unions

Algebrik AI and Open Lending Partner to Expand Intelligent Auto Loan Decisioning for Credit Unions

Yahoo2 days ago
NEW YORK, Aug. 11, 2025 /PRNewswire/ -- Algebrik AI Inc., a Delaware-incorporated company headquartered in New York City and pioneering the world's first cloud-native, AI-powered, digital-era Loan Origination Platform (LOS), today announced an integration with Open Lending Corporation, an industry trailblazer in automotive lending enablement and risk analytics solutions for financial institutions.
This collaboration aims to strengthen auto loan decisioning capabilities within Algebrik's cloud-native, AI-powered LOS—part of the Algebrik One lending suite—enabling credit unions and community lenders to confidently extend credit to near- and non-prime borrowers while minimizing risk and streamlining workflows.
Enabling Risk-Aware Auto Lending at Scale Open Lending's Lenders Protection™ platform empowers financial institutions to safely approve near- and non-prime auto loans by combining real-time risk modeling, pricing optimization, and insurance-backed loan protection.
Through this partnership, Algebrik's Loan Origination System, part of Algebrik One, Algebrik's agentic AI-powered lending suite, now offers built-in access to the Lenders Protection™ platform, allowing credit unions to:
Evaluate near- and non-prime applicants using Open Lending's advanced decisioning engine
Receive real-time decisions (approved, counteroffer, or denied), including APR, terms, stipulations, and certificate numbers
Automatically surface stipulations tied to counter-offers (e.g., vehicle details, income verification) within the lending workflow of Algebrik's Loan Origination System
Leverage Open Lending's insured, risk-based decisioning directly within Algebrik's LOS- no external systems needed.
Algebrik AI's LOS delivers this capability through a unified, AI-powered experience—supporting both loan officer and borrower-facing workflows. Lenders can seamlessly manage counteroffers, display dynamic payment terms, and track certificate numbers, all within a single, modern interface.
Strategic Insight: Why This Partnership Matters
Pankaj Jain, Founder and CEO of Algebrik AI, commented on the partnership:
"We believe modern lending stacks must function as ecosystems—not toolkits. By partnering with Open Lending, we're deepening the intelligence of loan decisioning and giving lenders a seamless path to responsible loan growth. With Open Lending now embedded in Algebrik's LOS, lenders can reach underserved borrowers while maintaining the operational efficiency and compliance they demand."
Josh Marcy, Chief Product Officer at Open Lending, added:
"Algebrik brings a modern, purpose-built approach to lending infrastructure. The Algebrik integration leverages best practice automation capabilities and a dynamic user experience, offering fast and accurate automatic decisions that accelerate loan originations for our mutual customers. Their team has delivered a clean, intuitive experience that aligns with our vision for the future of inclusive, data-driven auto lending. "
For more information on how Algebrik AI is transforming lending, visit https://www.algebrik.ai.
For latest on cutting edge lending technology & AI, follow Algebrik AI on Linkedin at: https://www.linkedin.com/company/algebrik-ai.
Or chat with the Algebrik AI team at: letschat@algebrik.com.
About Algebrik AI
Algebrik AI, headquartered in New York City, is the company behind Algebrik One: the world's first cloud-native, AI-powered, digital-era Loan Origination Suite (LOS), designed for the next generation of members. In an industry that hasn't seen significant innovation in lending technology in over 25 years, it was high time someone stepped in to help credit unions of all sizes regain their former glory.
Algebrik AI's mission is to empower credit unions to attract, engage, grow, and retain next-gen members while staying competitive in today's digital era. With Algebrik One, an end-to-end lending suite that includes Digital Account Opening, Lender's Cockpit (LOS), Omni-channel Point of Sale (PoS), AI Decision Engine, and Portfolio Analytics, we take on the heavy lifting; so credit unions can focus on helping the members and communities they serve. For more information, visit www.algebrik.ai
About Open Lending
Open Lending provides loan analytics, risk-based pricing, risk modeling, and default insurance to auto lenders throughout the United States. For over 20 years we have been empowering financial institutions to create profitable auto loan portfolios with less risk and more reward. For more information, please visit www.openlending.com.
Media Contacts:
Prateek Samantaray
Chief Marketing Officer
letschat@algebrik.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/algebrik-ai-and-open-lending-partner-to-expand-intelligent-auto-loan-decisioning-for-credit-unions-302526459.html
SOURCE Algebrik
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Paired Power Secures Patent for PairTree™ Solar-Integrated EV Charger System
Paired Power Secures Patent for PairTree™ Solar-Integrated EV Charger System

Business Wire

time2 hours ago

  • Business Wire

Paired Power Secures Patent for PairTree™ Solar-Integrated EV Charger System

CAMPBELL, Calif.--(BUSINESS WIRE)-- Paired Power, a leading manufacturer of solar-powered electric vehicle (EV) charging systems, announced the award of U.S. Patent No. 12,375,024 for its innovative PairTree™ solar canopy solution. The patent, titled 'Solar canopy systems and methods,' formally recognizes Paired Power's proprietary approach to solar canopy installation, significantly expanding the deployment speed and accessibility of electric vehicle charging in situations with limited or no grid power. This marks the company's fourth patent since 2016, reinforcing its position as the innovator in solar powered EV charging. The newly patented technology covers a unique method for raising solar panels above a foundation using an integrated lift mechanism. Unlike conventional canopy installations that require elevated work, scaffolding, or external lifts, the PairTree™ system allows panels to be safely assembled at ground level before being elevated into place. This streamlined approach reduces installation time, labor costs, and safety risks, making deployment of EV charging infrastructure faster with fewer approval bottlenecks in a wider range of environments. "Securing this patent for PairTree is a monumental achievement for Paired Power," said Tom McCalmont, CEO of Paired Power. 'It embodies our commitment to making sustainable energy solutions more accessible, efficient, and deployable for everyone, everywhere. The ability to rapidly install solar canopies with minimal effort will accelerate the adoption of electric vehicles by providing charging options in previously underserved locations." PairTree reduces installation time from weeks to hours, enabling rapid deployment with immediate functionality and minimal site disruptions. Unlike traditional EV chargers that require trenching and major construction, PairTree preserves existing parking spaces and reduces or eliminates reliance on the grid during installation. Paired Power's signature combination of solar power and energy storage allows PairTree to create its own self-powered microgrid, further enhancing the solution's utility for remote, off-grid or utility-constrained locations. By generating and storing its own energy, the system also empowers operators to avoid costly demand charges often levied by utilities during peak energy use. Its modular, flexible design enables fast, cost-effective EV charger deployment where and when it's needed most. To learn more about the PairTree™ system, visit To delve further into the company's full suite of microgrid EV charging solutions, join Paired Power on Thursday, September 18, for a live webinar at 2:00pm EDT/11:00am PDT. About Paired Power: Trusted by cities, governments, and leading corporations, Paired Power manufactures solar-powered microgrid electric vehicle charger facilities (EVCF) that enable rapid deployment of new EV infrastructure without requiring expansions of existing grid capacity. Paired Power's flagship products are PairTree™, a microgrid solar powered EV charger that pairs a 4.6kW solar array with a 42.4 kWh Battery Energy Storage System (BESS) to provide Level 2 EV charging day or night, and PairFleet™, a larger microgrid designed to serve greater numbers of vehicle charging needs and can be customized based on a client's energy requirements. For more information about Paired Power, visit

SWBC Mortgage Expands Access with Down Payment Grant Program
SWBC Mortgage Expands Access with Down Payment Grant Program

Business Wire

time2 hours ago

  • Business Wire

SWBC Mortgage Expands Access with Down Payment Grant Program

SAN ANTONIO--(BUSINESS WIRE)--SWBC Mortgage Corporation is proud to announce the continued success of its Homeownership Expansion Loan Program (HELP™), which has already helped hundreds of families and individuals achieve the dream of homeownership. Since its launch, the program has provided more than $2.3 million in down payment assistance and supported the closing of 487 home loans across the country. This program is about making homeownership more accessible, whether it's your first home or your next. Share HELP™ is a grant program designed to reduce the upfront costs of purchasing a home. Available to both first-time and repeat homebuyers, the program offers a grant of up to 2% of the home's purchase price (up to $5,000) when the buyer contributes at least 1% toward the down payment. First-time homebuyers meeting a 50% Area Median Income (AMI) may also qualify for an additional $2,500 in assistance. Unlike a loan, the grant does not require repayment, making it a powerful tool for increasing access to homeownership. Eligibility is based on income, with assistance available to borrowers earning 80% or less of the area median income (AMI). Borrowers receive a Form 1099 for grant funds utilized. Applicants should consult a tax preparer to determine whether the funds may be taxable. 'This program is about making homeownership more accessible, whether it's your first home or your next,' said Susan Stewart, CEO of SWBC Mortgage. 'We're giving buyers a head start without burdening them with extra debt.' Program Benefits Include: Up to $5,000 in down payment assistance No repayment of assistance funds required (funds may be taxable) Available to eligible first-time and repeat buyers Backed by conventional loan financing Lower mortgage insurance (MI) compared to many other loan options Temporary buydown options available for reduced initial monthly payments No interest rate difference if the buyer uses the grant This innovative grant solution offers financial flexibility and support, helping to reduce some of the upfront challenges of home buying. For more information about the SWBC Mortgage's Homeownership Expansion Loan Program™ and to see if you qualify, please visit our website. About SWBC Mortgage Corporation SWBC Mortgage Corporation, a wholly owned subsidiary of SWBC, is a full-service mortgage lender approved by FNMA, FHLMC, and GNMA. Headquartered in San Antonio, Texas, SWBC Mortgage has been providing mortgage banking services since 1988. Through the changing landscape of the mortgage industry, the company has remained committed to service, integrity, and stability while growing to serve communities and borrowers in 44 states + D.C. Today, SWBC Mortgage is consistently recognized as one of the top 50 lenders in America and is home to numerous top-ranked originators. Building on a rich history of success, SWBC Mortgage has highly experienced team members who leverage streamlined digital tools to deliver efficient service and support, while providing a personal, experienced touch to the mortgage process. SWBC Mortgage provides innovative technology and resources built to streamline the mortgage process and provide support from application through servicing. About SWBC As a diversified financial services company, SWBC provides financial institutions, businesses, and individuals with a wide range of insurance, mortgages, wealth management, employee benefits, and more. Headquartered in San Antonio, Texas, SWBC has partners and divisions across all 50 states and Mexico and manages businesses worldwide. No matter how wide its reach, SWBC always listens to our customers' needs, analyzes their current situations, and recommends customized solutions. For more information about our innovative approach to personalized service, visit SWBC's website. SWBC Mortgage Corporation, NMLS #9741. Check licensing at AZ BK #0950067; Licensed by the Department of Financial Protection and Innovation under the California Residential Mortgage Lending Act #4130449; Licensed by the N.J. Dept. of Banking and Insurance. Massachusetts Mortgage lender & Mortgage Broker License MC9741. Loans subject to credit and property approval, restrictions and conditions may apply. Not all loan programs or loan amounts available in all areas. Programs and guidelines subject to change without notice. Corporate office: 9311 San Pedro Ave., Ste. 100, San Antonio, TX 78216. © 2025 SWBC. All rights reserved.

Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform
Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform

Business Wire

time3 hours ago

  • Business Wire

Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced a significant advancement in the global fight against tuberculosis (TB) with an investigational prototype for Mycobacterium tuberculosis (MTB) detection on its SeekIt™ platform. In internal analytical testing, the MTB SeekIt test delivered accurate results in under 60 minutes. Importantly, this innovation addresses a key limitation that has historically hindered effective TB diagnostics: breaking apart MTB's waxy, lipid-rich cell wall to gain access to detectable genetic material. In internal testing, SeekIt's proprietary chemical lysis step achieved this in just 15 minutes without heat, mechanical disruption, or complex lab tools and skilled operators. Seek Labs achieved a functional investigational prototype in one quarter by leveraging its suite of in-house, pre-validated diagnostic technologies, focusing new innovation efforts on the MTB-specific lysis step. Share Seek Lab's MTB test demonstrates the speed, adaptability, and field-readiness of the modular SeekIt platform. All SeekIt's components—lysis chemistry, extraction, amplification, and detection—are proprietary to Seek Labs, exclusively discovered and developed in-house, and have been internally validated for performance and integration across multiple applications. The Global TB Testing Gap TB kills more than 1.25 million people each year, with nearly one in three cases going undiagnosed. In high-burden, resource-limited settings, centralized molecular tests face major hurdles: Pathogen complexity: MTB's waxy, lipid-rich cell wall has proven intractable to portable lysis methods for decades. Infrastructure dependence: Gold-standard molecular tests require expensive, power-intensive instruments, refrigeration, and highly skilled (or trained) operators. Sample limitations: Sputum collection is challenging for many patients and can deter testing. 'TB diagnostics have long been limited by gaps in both infrastructure and innovation that have often meant severe consequences for patient care and public health,' said Jared Bauer, CEO of Seek Labs. 'Our rapid, point-of-care SeekIt MTB test is designed to enable molecular-level detection in settings where access to equipment and electricity may be limited.' From Sample to Result: A Simplified Workflow At the core of the MTB SeekIt test is a proprietary, single-step chemical lysis buffer, involving a specially-formulated solution that disrupts MTB cells to release their genomic DNA. This breakthrough innovation takes just 15 minutes at room temperature, while competing methods (high-heat incubation or mechanical bead-beating) require longer times plus expensive equipment, specialized technicians, and complex infrastructure. More importantly, the integrated SeekIt test means the lysate itself flows seamlessly into SeekIt's downstream test components: Seek Extraction™ — A proprietary membrane-based binding system, developed and validated by Seek Labs, that rapidly captures MTB DNA without lab instruments. In validation testing, the MTB DNA yield for Seek Extraction was consistently more than 70% when compared to leading spin-column kits. Seek Amplification™ — A proprietary process that exponentially copies DNA at a constant temperature, detecting as few as 10 MTB genomic copies in 30 minutes without thermal cycling (internally validated), the conventional lab-based method. Molecular Lateral Flow Assay (mLFA) — A test strip that delivers clear, visual results in minutes indicating the presence of amplified DNA in a manner that can be optionally paired with the SeekIt mobile app for digital analysis and connectivity. Speed as a Strategy Conventional development of a molecular test for MTB can take a year or more. Seek Labs achieved a functional investigational prototype in one quarter by leveraging its suite of in-house, pre-validated diagnostic technologies, focusing new innovation efforts on the MTB-specific lysis step. This rapid-deployment approach illustrates how SeekIt can be rapidly developed for numerous high-priority diseases in record time. 'This was more than a fast project; it's proof of our platform's flexibility,' said Kim Wirthlin, Chief Strategy Officer. 'By focusing our innovation on the MTB-specific lysis step for compatibility with our downstream isothermal amplification, we solved one of TB diagnostics' toughest technical challenges and produced a functional investigational prototype in a single quarter.' From Conference to Collaboration Seek Labs will debut the MTB SeekIt prototype at the 2025 Next Generation Dx Conference (August 18–20, 2025, Washington, D.C.), including: Podium Presentation — Enabling Point of Care Diagnostics Track, Tuesday, August 19 at 10:00 AM ET. Scientific Poster — Detailing the proprietary lysis chemistry, rapid development process, and validation data. Seek Labs is actively seeking partners across global health (ministries of health, TB-focused NGOs, and diagnostics distributors in high-burden regions such as sub-Saharan Africa and Southeast Asia) to advance the MTB SeekIt test through clinical validation, regulatory approval, and deployment. 'Innovation means nothing if it doesn't reach people,' said Bauer. 'We want to work with those who share our vision to advance development of accurate, accessible TB testing solutions wherever they're needed most.' About Seek Labs At Seek Labs, we don't wait for change—we build it. We're pursuing the breakthroughs the world can't wait for by developing programmable 'seek-and-destroy' therapeutics and point-of-care molecular diagnostics that close the gap between outbreak and intervention. At the core of this mission is a layered architecture: BioSeeker™ serves as the Intelligence Layer, continuously mapping conserved viral vulnerabilities in real time; these insights activate our Deployment Layers (PTAP™ for programmable therapeutics and SeekIt™ for molecular diagnostics), forming a full-stack development engine designed to accelerate response, innovation, and impact across global health. Headquartered in Salt Lake City, Seek Labs is a proud member of BioHive, Utah's collaborative life sciences ecosystem. Together with our partners, we're building faster, smarter solutions for the world's most urgent health challenges. Forward-Looking Statements and Regulatory Disclaimer This press release contains forward-looking statements, including statements regarding development timelines, clinical validation, regulatory pathways, and potential collaborations. Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties—including scientific, regulatory, manufacturing, clinical, and commercial risks—that could cause actual results to differ materially. The MTB SeekIt assay is an investigational device. Limited by Federal law to investigational use.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store